Clinical trial
A Retrospective Multicenter Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
NCT03208660 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective Multicenter Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
- Lead sponsor
- Eisai Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 7, 2017
- Completion date
- March 15, 2019
- Enrollment
- 2,000 (actual)
- Sites
- 44
Conditions
As the registry lists them; a condition with its own page is linked.